| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 07/10/2003 | US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders |
| 07/10/2003 | US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2003 | US20030130281 DPP IV inhibitors |
| 07/10/2003 | US20030130279 Hyperglycemic agents; dietetics; cardiovascular disorders; immunology modulation; osteoporosis; cognition activators |
| 07/10/2003 | US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 07/10/2003 | US20030130271 1,3-Diheterocyclic metalloprotease inhibitors |
| 07/10/2003 | US20030130265 Benzimidazole derivatives, a process for their manufacture and use as a medicine |
| 07/10/2003 | US20030130259 Quinoline and quinazoline compounds useful in therapy |
| 07/10/2003 | US20030130258 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/10/2003 | US20030130253 Central nervous system disorders; skin disorders; appetite suppressants |
| 07/10/2003 | US20030130251 Blocking amyloid deposits; Alzheimer's disease, Down syndrome |
| 07/10/2003 | US20030130234 Novel indolinones and uses thereof |
| 07/10/2003 | US20030130198 Binding nucleic acids; microbiocides |
| 07/10/2003 | US20030130125 Pesticides; herbicides |
| 07/10/2003 | US20030129552 Color photothermography |
| 07/10/2003 | CA2471049A1 Amide derivatives as gk activators |
| 07/09/2003 | EP1325920A1 N-substituted benzothiophenesulfonamide derivatives |
| 07/09/2003 | EP1325913A2 Piperidinecarboxylic acid amide derivatives |
| 07/09/2003 | EP1325910A1 Aliphatic nitrogenous five-membered ring compounds |
| 07/09/2003 | EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 07/09/2003 | EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 07/09/2003 | EP1324984A1 Butenolide and pentenolide derivatives as kinase inhibitors |
| 07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
| 07/09/2003 | EP1324759A2 Nf-g(k)b inhibitors |
| 07/09/2003 | EP0960100B1 Substituted 4-benzoyl-pyrazoles |
| 07/09/2003 | EP0823906B1 Piperazino derivatives as neurokinin antagonists |
| 07/09/2003 | CN1429225A C10 carbonate substituted taxanes as antitumor agents |
| 07/09/2003 | CN1429224A Novel benzothiophene derivatives |
| 07/09/2003 | CN1429223A Novel benzofuran derivatives |
| 07/09/2003 | CN1429215A 三唑衍生物 Triazole derivatives |
| 07/09/2003 | CN1429210A Substituted thioacetamides |
| 07/09/2003 | CN1428340A 3,7,8-trisubstituted-5-hydrobenzo-gamma-pyranone compound and its preparation method |
| 07/09/2003 | CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist |
| 07/09/2003 | CN1113894C Process for preparing intermediates of inhibitors of enkephalinase and angiotensin coverting enzyme and intermediates thereof |
| 07/09/2003 | CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/09/2003 | CN1113862C Arysulfonylamino hydroxamic acid derivs. |
| 07/08/2003 | US6589984 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as |
| 07/08/2003 | US6589963 Drug salt thereof show a hypoglycemic action, a blood hypolipidemic action, an insulin resistance-improving action and a PPAR activating action, and are useful as a hypoglycemic agent, a hypolipidemic agent, an insulin |
| 07/08/2003 | US6589956 Its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as a TXA2 receptor antagonist and 5-HT2 receptor antagonist. |
| 07/08/2003 | US6589953 Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 07/03/2003 | WO2003053969A1 Imidazoquinoline derivatives |
| 07/03/2003 | WO2003053959A1 Heterocyclylamino carbonyluracils |
| 07/03/2003 | WO2003053955A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 07/03/2003 | WO2003053954A1 Benzothiophenes as adenosine receptor modulators |
| 07/03/2003 | WO2003053948A1 Isochroman compounds for treatment of cns disorders |
| 07/03/2003 | WO2003053944A1 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 07/03/2003 | WO2003053939A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 07/03/2003 | WO2003053938A1 Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten |
| 07/03/2003 | WO2003053936A1 Dopamine d1 receptor agonist pro-drug compounds & derivatives |
| 07/03/2003 | WO2003053934A1 Improved compounds for generating chemiluminescence with a peroxidase |
| 07/03/2003 | WO2003053933A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 07/03/2003 | WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | WO2003053368A2 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 07/03/2003 | WO2003053360A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/03/2003 | WO2003053331A2 Protease inhibitors |
| 07/03/2003 | WO2002101073A3 Aryl-benzimidazole compounds having antiinfective activity |
| 07/03/2003 | WO2002062295A3 Pyridine-substituted benzanilides as potassium ion channel openers |
| 07/03/2003 | WO2002016340A8 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 07/03/2003 | US20030125562 Functionalized 4-imino-3-mercapto-1,2,4-triazoles as inhibitors of nitric oxide synthase (NOS) and as inhibitors of malignant cell growth |
| 07/03/2003 | US20030125557 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/03/2003 | US20030125369 New indenoindolone compounds |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125344 Rho-kinase inhibitors |
| 07/03/2003 | US20030125340 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases |
| 07/03/2003 | US20030125339 Substituted alkylamine derivatives and methods of use |
| 07/03/2003 | US20030125334 5-HT receptor ligands and uses thereof |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | CA2471098A1 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 07/03/2003 | CA2470938A1 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/03/2003 | CA2470931A1 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | CA2469872A1 Benzothiophenes as adenosine receptor modulators |
| 07/03/2003 | CA2469278A1 Isochroman compounds for treatment of cns disorders |
| 07/03/2003 | CA2448811A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 07/03/2003 | CA2436850A1 Protease inhibitors |
| 07/02/2003 | EP1323716A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
| 07/02/2003 | EP1323710A1 Nitrogenous five-membered ring compounds |
| 07/02/2003 | EP1322650A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322644A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
| 07/02/2003 | EP1322643A1 Piperazin-2-one amides as inhibitors of factor xa |
| 07/02/2003 | EP1322642A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
| 07/02/2003 | EP1322641A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 07/02/2003 | EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322635A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 07/02/2003 | EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai |
| 07/02/2003 | EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists |
| 07/02/2003 | EP1322627A1 Cyclic sulfonyl compounds as inhibitors of metalloproteases |
| 07/02/2003 | EP1322624A1 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 07/02/2003 | EP1322619A1 Isoquinolinone potassium channel inhibitors |
| 07/02/2003 | EP1322611A1 Chemical compounds |
| 07/02/2003 | EP1322610A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
| 07/02/2003 | EP1322608A1 Delta1-pyrrolines used as pesticides |
| 07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
| 07/02/2003 | EP1322331A2 Fatty acid synthase inhibitors |
| 07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
| 07/02/2003 | EP1224180B1 Substituted azoles |
| 07/02/2003 | EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP0841916B1 Endothelin receptor antagonists |
| 07/02/2003 | EP0740658B1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics |